Immunogen reported $60.93M in Operating Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 8821M 991M
Agios Pharmaceuticals AGIO:US $ 99.27M 2.91M
Amgen AMGN:US $ 3.74B 804M
Astellas Pharma 4503:JP 317.56B 56.13B
AstraZeneca AZN:LN 10.51B 1.79B
Bluebird Bio BLUE:US $ 122.29M 14.98M
Bristol Myers Squibb BMY:US $ 9.1B 247M
Cerulean Pharma CERU:US $ 8.4M 1.14M
Eli Lilly And LLY:US $ 5405.7M 677M
Emergent Biosolutions EBS:US $ 301.1M 144.7M
Exelixis EXEL:US $ 272.74M 61.76M
Halozyme Therapeutics HALO:US $ 41.61M 3.86M
Heron Therapeutics HRTX:US $ 86.38M 12.19M
Immunogen IMGN:US $ 60.93M 1.62M
Intrexon XON:US $ 49.92M 5.21M
Karyopharm Therapeutics KPTI:US $ 82.26M 2.95M
Macrogenics MGNX:US $ 77.74M 5.36M
Nektar Therapeutics NKTR:US $ 141.38M 3.46M
Novartis NVS:US 9.96B 998M
Pfizer PFE:US $ 15788M 3271M
Regeneron Pharmaceuticals REGN:US $ 1706.6M 605.4M
Seattle Genetics SGEN:US $ 559.51M 42.41M